The scale-up becomes a decacorn thanks to a new round of equity investment that values it at $11 billion

Between the green funding crisis and geopolitical pressures, European start-ups reinvent themselves by focusing on defence and AI

The start-up has the ambition to train one million people in artificial intelligence, data science and machine learning

The biotech company sells shares worth a gross value of $15 million to US investment funds, placed by Maxim Group and Rodman & Renshaw